Vanderbilt University Medical Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Vanderbilt University Medical Center brings 1 presentation to ASH 2026 in New Orleans. Its program covers treatment decisions in MDS and makes the case for bispecific antibodies in myeloma, set against CAR T. It also contributes to professional development for training program directors.
| Organization | ASH 2026 Attendance |
|---|---|
Vanderbilt University Medical Center Nashville, TN | |
Nonprofit academic medical center in Nashville, Tennessee, with hospitals, clinics and the Vanderbilt-Ingram Cancer Center. | Symposium Fri Dec 11 7:00am–10:00am MDS in Practice: Navigating Complex Decisions Across the Disease Spectrum Managing myelodysplastic neoplasms across their spectrum, from clonal hematopoiesis and lower- and higher-risk disease to overlap syndromes and leukemia. Session Training Program Directors Workshop Supporting trainees' careers and research funding in a tough political climate, AI guidelines for fellows, and how applicants signal interest in programs. |
Instantly find 20 buyers from Vanderbilt University Medical Center
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction